Dipeptidyl peptidase-4 (DPP4) inhibitors
Drug / Medication
A class of drugs that increase endogenous GLP-1 and GIP levels, but are not strong enough to provide a long-lasting effect, as shown in the GRADE study.
Mentioned in 1 video
A class of drugs that increase endogenous GLP-1 and GIP levels, but are not strong enough to provide a long-lasting effect, as shown in the GRADE study.